- By Anton Grillo
- (General Dispatch) – After registering secondary alterations in the vaccine, Astrazeneca comes back completely renewed, assuring that its immunization has a great protection.
- In a recent study, the drug maker assured that despite the diseases that may be found in people’s bodies, the vaccine is completely safe.
- In a late-night press release Wednesday, AstraZeneca said it had analyzed more data from that study and concluded that the vaccine is 76% effective in preventing symptomatic COVID-19.
- The clinical trials have yielded more reliable results, after having had certain adverse circumstances in the United States. Because of the side effects that caused alterations in the organism.
- Experts assure that the company is doing a very hasty job, that the accusations still weigh and that it is too premature to issue a statement of reliability.
- Dr. Anthony Fauci, an expert in infectious diseases in North America, indicated that the current vaccine must be evaluated by the FDA, and projections are that it will be an “excellent vaccine”.
- Having overcome the incident of blood clot formation, the company is directing all its efforts to return to the competitive market and satisfy demand, after receiving the support of the European Medicines Agency.
- The European Union is clamoring for the arrival of the immunization in its countries, which are still recording low immunization figures in difficult times when the coronavirus is back.
Adittional Information:
Breitbart: AstraZeneca confirms strong vaccine protection after US rift
ABC News: AstraZeneca confirms strong vaccine protection after US rift
